Table 1 Prior treatment regimens and dose specifications by tumor type
Number | Median dose | Dose range | IOERT | IOERT | |
|---|---|---|---|---|---|
median dose | dose range | ||||
A. Cervical cancer | |||||
Cervical cancer (n = 18) | |||||
Resection | 17 | – | – | – | – |
EBRT alone | 5 | 52.5 | 45–55.6 | 15 | 12–15 |
EBRT + CHT | 8 | 50.4 | 50.4–58.5 | 15 | 10–18 |
EBRT + Brachytherapy | 4 | 50 + 20 | 36–50.4 + 15–40 | 15 | 12–15 |
Brachytherapy alone | 0 | – | – | – | – |
CHT alone | 2 | – | – | – | – |
No prior radiation | 4 | – | – | 12 | 10–15 |
B. Endometrial cancer | |||||
Endometrial cancer (n = 12) | |||||
Resection | 12 | – | – | – | – |
EBRT alone | 1 | 50.4 | – | 15 | 15 |
EBRT + CHT | 0 | – | – | – | – |
EBRT + Brachytherapy | 1 | 50.4 + 20; 50 | – | 10 | 10 |
Brachytherapy alone | 7 | 21 | 15–30 | 15 | 10–15 |
CHT alone | 2 | – | – | – | – |
No prior radiation | 3 | – | – | 15 | 10–15 |
C. Vulvar cancer | |||||
Vulvar cancer (n = 6) | |||||
Resection | 6 | – | – | – | – |
EBRT alone | 5 | 50.4 | 50–61.2 | 15 | 12–15 |
EBRT + CHT | 1 | n.a. | n.a. | 15 | 15 |
EBRT + Brachytherapy | 0 | – | – | – | – |
Brachytherapy alone | 0 | – | – | – | – |
CHT alone | 0 | – | – | – | – |
No prior radiation | 0 | – | – | – | – |